Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5.75 EUR
−45.37 M EUR
6.52 M EUR
16.36 M
About T2 BIOSYSTEMS NEW DL-,001
Sector
Industry
CEO
John J. Sperzel
Website
Headquarters
Lexington
Founded
2006
FIGI
BBG006Z57L66
T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens. It offers T2Dx instrument, T2Bacteria, T2Candida, T2Biothreat panels, and T2MR technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 3T2 is 0.10 EUR — it has decreased by −16.32% in the past 24 hours. Watch T2 BIOSYSTEMS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange T2 BIOSYSTEMS INC stocks are traded under the ticker 3T2.
3T2 stock has fallen by −54.75% compared to the previous week, the month change is a −65.40% fall, over the last year T2 BIOSYSTEMS INC has showed a −97.94% decrease.
3T2 stock is 19.50% volatile and has beta coefficient of 0.09. Track T2 BIOSYSTEMS INC stock price on the chart and check out the list of the most volatile stocks — is T2 BIOSYSTEMS INC there?
Today T2 BIOSYSTEMS INC has the market capitalization of 2.12 M, it has decreased by −39.41% over the last week.
Yes, you can track T2 BIOSYSTEMS INC financials in yearly and quarterly reports right on TradingView.
T2 BIOSYSTEMS INC is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
3T2 earnings for the last quarter are −0.51 EUR per share, whereas the estimation was −0.57 EUR resulting in a 10.94% surprise. The estimated earnings for the next quarter are −0.47 EUR per share. See more details about T2 BIOSYSTEMS INC earnings.
T2 BIOSYSTEMS INC revenue for the last quarter amounts to 1.78 M EUR, despite the estimated figure of 2.56 M EUR. In the next quarter, revenue is expected to reach 3.56 M EUR.
3T2 net income for the last quarter is −9.09 M EUR, while the quarter before that showed −8.37 M EUR of net income which accounts for −8.59% change. Track more T2 BIOSYSTEMS INC financial stats to get the full picture.
No, 3T2 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 13, 2025, the company has 113.00 employees. See our rating of the largest employees — is T2 BIOSYSTEMS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. T2 BIOSYSTEMS INC EBITDA is −37.18 M EUR, and current EBITDA margin is −643.60%. See more stats in T2 BIOSYSTEMS INC financial statements.
Like other stocks, 3T2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade T2 BIOSYSTEMS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So T2 BIOSYSTEMS INC technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating T2 BIOSYSTEMS INC stock shows the sell signal. See more of T2 BIOSYSTEMS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.